TransCode Therapeutics Inc

RNAZ NASDAQ Santé & Biotech États-Unis US89357L1052
5.60 $
4.11 %

TransCode Therapeutics Inc est axée sur la recherche et le développement de traitements oncologiques innovants utilisant la technologie de l'ARN.

Performance & Momentum

6 Months 48.33 %
1 Year 38.15 %
3 Years 100.00 %
5 Years 100.00 %

Similar stocks to TransCode Therapeutics Inc

Anantys Community

Be the first to share your analysis on TransCode Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases